Sort
82,697 grants matching “vaccine development”
Discovery of Chemical Probes and Therapeutic Leads, Phase II
$2,399,995Joseph M Fox · University Of Delaware · P20 · FY2024 · GM
SPORE in Prostate Cancer
$2,399,558Baylor College Of Medicine · P50 · FY2004 · CA
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis
$2,399,184Jerrold J. Ellner · Rbhs-New Jersey Medical School · U19 · FY2018 · AI
Columbia Collaborative HIV/AIDS Clinical Trials Unit
$2,398,203Scott M Hammer · Columbia University Health Sciences · U01 · FY2010 · AI
PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM
$2,397,983Fred Hutchinson Cancer Research Center · P50 · FY2000 · CA
Tick saliva and its importance for tick feeding and pathogen transmission
$2,397,882Lucas Tirloni · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
University of Puerto Rico Clinical Trials Unit
$2,397,451Carmen D Zorrilla · University Of Puerto Rico Med Sciences · UM1 · FY2012 · AI
Adjuvant Development Program in the context of vaccines to protect against Y. pestis and Shigella.
$2,396,894Robert Ernst · University Of Maryland Baltimore · N01 · FY2019 · AI
Reagent Resource Support Program for AIDS Vaccine Development
$2,396,840Valerie Fremont · Quality Biological, Inc. · N01 · FY2019 · AI
HIV/AIDS Vaccine and Antibody Development
$2,396,730John Mascola · National Institute Of Allergy And Infectious Diseases · ZIC · FY2021 · AI
Tulane National Primate Research Center
$2,396,052Lee Hamm · Tulane University Of Louisiana · P51 · FY2023 · OD
Immunobiology and Pathogenesis of Pulmonary Tularemia
$2,394,479Dennis W. Metzger · Albany Medical College · P01 · FY2010 · AI
Immunological Analysis of Brain Cancer
$2,394,103Masaki Terabe · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Case Clinical Trials Unit
$2,393,908Jeffrey M Jacobson · Case Western Reserve University · UM1 · FY2024 · AI
Vaccines for prescription opioid and heroin abuse
$2,393,499Paul Pentel · Hennepin Healthcare Research Institute · U01 · FY2017 · DA
Anti-viral immune responses in lymph node
$2,393,299Ulrich H Von Andrian · Harvard Medical School · P01 · FY2011 · AI
Task A13 Small animal model development for invasive fungal disease
$2,393,023Thomas Patterson · University Of Texas Hlth Science Center · N01 · FY2011 · AI
Optimization Of HIV Specific Immune Responses In Vivo
$2,392,577Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Center for Molecular, Cellular, and Translational Immunological Research
$2,391,835William R Green · Dartmouth College · P20 · FY2006 · RR
Northwestern University Clinical Trial Unit
$2,390,396Robert L. Murphy · Northwestern University At Chicago · U01 · FY2007 · AI
NIAID Preclinical Development Support
$2,390,291Phillip Ishikawa · Advanced Bioscience Laboratories, Inc. · N01 · FY2016 · AI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces
$2,390,117Robert A Britton · Baylor College Of Medicine · U19 · FY2021 · AI
A NOVEL VEE REPLICON VACCINE FOR HIV
$2,389,569University Of North Carolina Chapel Hill · P01 · FY2000 · AI
Anti-viral immune responses in lymph node
$2,389,184Ulrich H Von Andrian · Harvard Medical School · P01 · FY2010 · AI
Genetic Analysis of T-cell Differentiation
$2,388,750Remy Bosselut · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA